Section Arrow
VCYT.NASDAQ
- Veracyte
  suspend
Quotes are at least 15-min delayed:2026/04/28 10:29 EDT
Regular Hours
Last
 33.18
-0.67 (-1.98%)
Day High 
33.88 
Prev. Close
33.85 
1-M High
35.19 
Volume 
43.54K 
Bid
33.06
Ask
33.22
Day Low
33.11 
Open
33.82 
1-M Low
29.88 
Market Cap 
2.70B 
Currency 美元 
P/E 41.28 
%Yield -- 
10-SMA 33.72 
20-SMA 32.82 
50-SMA 33.67 
52-W High 50.71 
52-W Low 22.61 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.82/1.63
Enterprise Value
2.74B
Balance Sheet
Book Value Per Share
16.41
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
517.15M
Operating Revenue Per Share
4.30
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QGENQiagen NV33.8625-4.2275-11.10%18.65PE
BIAFbioAffinity Technologies Inc2.6+0.39+17.65%-- 
DHRDanaher Corp177.81-2.81-1.56%35PE
GHGuardant Health84.56-3.94-4.45%-- 
ICLRICON plc101.6225-1.5875-1.54%13.91PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.